Xenopus Nodal-related (Xnr) 5 is one of the earliest expressed components of a network of TGF-b factors participating in endoderm and mesoderm formation. Zygotic gene expression is not required for induction of Xnr5; rather, expression is dependent on the maternal factors VegT, localised throughout the vegetal pole, and b-catenin, functional in the future dorsal region of the embryo. Using transient assays with a luciferase reporter in Xenopus embryos, we have defined a minimal promoter, which mimics the response of the endogenous gene to applied factors. Expression of luciferase from the minimal promoter is dorsal-specific and requires two T-box half sites and a functional bcatenin/XTcf-3 pathway. Mutation of two Tcf/Lef sites in the minimal promoter permits induction by VegT to wild-type promoter levels in the presence of a dominant-negative XTcf-3, indicating that b-catenin/XTcf-3 are repressive and are not required as transactivators of Xnr5 transcription. The activity of the Tcf/Lef mutant promoter is similar in both ventral and dorsal sides of the embryo. In transgenic experiments, the dorsal specificity of expression of a b-gal reporter driven by the wild-type minimal promoter is abolished upon mutation of these Tcf/Lef sites. We propose a model in which XTcf-3 functions as a repressor of Xnr5 throughout the blastula embryo, except where repression is lifted by the binding of b-catenin in the dorsal region. This removal of repression allows activation of the promoter by VegT in the dorsal vegetal region. Subsequently, zygotically expressed LEF1 supersedes the role of b-catenin/XTcf-3. q
Introduction
In recent years, much progress has been made in the identification and characterisation of signalling molecules involved in early patterning events such as dorsal axis formation and mesoderm induction in early Xenopus embryos. Models for early embryonic patterning involve the maternally-localised factor VegT, which has an essential role in the induction of zygotic genes involved in germ layer specification (Zhang et al., 1998) . Downstream of VegT, there is evidence for a network of genes, including multiple TGF-bs, which participate in endoderm and mesoderm formation and patterning (Clements et al., 1999; Yasuo and Lemaire, 1999; Kofron et al., 1999; Xanthos et al., 2001) . Essential roles for Nodal-related genes within this network have been demonstrated by the use of constructs such as cer-S specifically to knock out Nodal-related function (Piccolo et al., 1999; Agius et al., 2000) and cleavage mutants to interfere with Nodal-related protein processing Onuma et al., 2002; Eimon and Harland, 2002) .
Studies in Xenopus have demonstrated a requirement for Nodal-related factors (Xnrs) in mesoderm formation (reviewed by Schier and Shen, 1999) . Six Xnrs have been documented and all but Xnr3 have mesoderm-inducing characteristics (Jones et al., 1995; Lustig et al., 1996; Smith et al., 1995; Joseph and Melton, 1997; Takahashi et al., 2000; Yakota et al., 2003) . In late blastula embryos, Xnrs1, 2, 4, 5 and 6 are exclusively zygotically expressed in a dorsal domain, although the patterns differ in detail for each gene. Xnr5 is of particular relevance to the work reported here. Xnr5 expression can be detected by in situ hybridisation in the future dorsal endoderm at stage 8.5 (Takahashi et al., 2000) . Expression of Xnr5 is unaffected by cycloheximide treatment from stage 7, indicating that induction is wholly dependent on maternal factors (Rex et al., 2002) . Recent work has shown that Xnr5 expression can be detected prior to mid-blastula transition as early as the 256-cell stage, suggesting a pivotal role for this gene in the earliest zygotic events initiating the TGF-b network (Yang et al., 2002a) .
Previous work has shown that expression of Xnr5 in the late blastula (stage 9) is dependent on the simultaneous activities of VegT and the Tcf/Lef/b-catenin pathway (Rex et al., 2002; Hashimoto-Partyka et al., 2003) . Neither VegT nor b-catenin alone can induce Xnr5. The previously observed induction by VegT in animal caps is due to concomitant activation of the Tcf/Lef/b-catenin pathway (Rex et al., 2002) . A summary of interactions involved in the regulation of Xnr5 is given in Fig. 1 .
The Tcf/Lef family of transcription factors are effectors of the canonical Wnt signalling pathway (reviewed by Cadigan and Nusse, 1997; Brantjes et al., 2002) . XTcf-3 is maternally expressed throughout the embryo (Molenaar et al., 1996) . In addition to binding DNA and b-catenin (Molenaar et al., 1996) , XTcf-3 has been shown to interact with various repressor molecules, including Groucho and XCtBP (Brannon et al., 1999) . In Drosophila, dTcf has been shown to be acetylated by dCBP, interfering with the binding of b-catenin and leading to a decrease in transcriptional activation of target genes (Walter and Bienz, 1998) . In the absence of b-catenin, XTcf-3 has the capacity to repress transcription of target genes (Brannon et al., 1997; Houston et al., 2002; Yang et al., 2002b) . Recent work has shown that depletion of maternal stores of XTcf-3 (by an antisense oligonucleotide approach) allows expression of certain dorsal-specific genes (e.g. siamois) on the ventral side of the embryo. It has been proposed that only where XTcf-3-mediated repression is lifted (e.g. by b-catenin on the dorsal side) can other transcription factors normally activate transcription of such dorsal-specific target genes on the dorsal side (Houston et al., 2002) .
Here, we report experiments aimed at examining the essential roles of VegT and b-catenin in regulating expression at the Xnr5 promoter. By overexpression of functional and dominant-negative constructs in whole embryos, by mutational analysis of promoter sites and by transgenic analysis of promoter action we have demonstrated that XTcf-3-mediated-repression of the Xnr5 promoter must be overcome to permit transcriptional activation by VegT in the dorsal-vegetal region of early embryos.
Results

Determination of the minimal Xnr5 promoter
To elucidate the mechanisms by which maternal determinants direct expression of Xnr5 in the future dorsal endoderm, we isolated the promoter region of the Xnr5 gene. A genomic library was screened and a clone obtained containing more than 785 bp of upstream sequence and all intronic and coding sequence (Genbank accession number AY050647). The nucleotide sequence within the coding region is approximately 93% identical to the sequence previously reported by Takahashi et al. (2000) . It is likely that the clone we have isolated corresponds to a pseudoallelic version of the previously reported Xnr5. There is no extensive homology between the proximal promoter regions of Xnr5 and Xnr6 (Genbank accession number AY050648), despite the two genes displaying similar temporal and spatial expression patterns and responses to exogenous signals (Takahashi et al., 2000; Rex et al., 2002) .
Inspection of the sequence reveals several putative response elements within the proximal 785 bp of Xnr5 promoter ( Fig. 2A ). There are several half sites matching the consensus sequence for T-box proteins (Kispert and Herrman, 1993) and sites for the Tcf/Lef family of transcription factors (Travis et al., 1991; Van De Wetering et al., 1991; Van Beest et al., 2000) . We also note putative sites for homeodomain proteins and Fast1, although no associated SMAD sites were found (Zhou et al., 1998) .
A 200 bp fragment is a minimal Xnr5 promoter
To determine a minimal Xnr5 promoter whose expression parallels the endogenous gene, a deletion series was generated (Fig. 2B) . The deletion series consists of five fragments, the 3 0 end of each fragment being 12 bp upstream of the ATG start codon (the adenine of the ATG codon is numbered as þ 1). Constructs have been named according to the total number of bases of Xnr5 promoter each contains, rather than according to the transcriptional start site. For example, Xnr5 (773) contains bases 2 12 to 2 785 bp, relative to the ATG. Previous work has shown that Xnr5 gene expression in early embryos requires both VegT and b-catenin. The requirement for VegT function has been demonstrated by antisense oligonucleotide-mediated VegT depletion (Takahashi et al., 2000) . The requirement for b-catenin has been inferred from experiments employing a dominant-negative (dn) XTcf-3 or a bcatenin specific morpholino (MO) antisense oligonucleotide (Rex et al., 2002) . XWnt8 can be used to stimulate b-catenin function through the canonical Wnt pathway (reviewed by Heasman, 1997; Cadigan and Nusse, 1997) .
Given that VegT is required for endogenous Xnr5 gene expression (Takahashi et al., 2000; Rex et al., 2002) , we tested the capability of each promoter fragment to activate a luciferase reporter gene in response to VegT mRNA in DNA-injected whole embryos, in a transient assay (Fig. 3A) . Each fragment was cloned into a luciferase reporter vector and DNA was injected into the animal pole of one-cell embryos. We observed expression of luciferase from all constructs except Xnr5 (122), demonstrating that, of the five fragments tested, the 200 bp promoter is the shortest capable of responding to VegT mRNA.
Expression of luciferase decreased as promoter length decreased except with Xnr5 (374), where the response to VegT was consistently higher than the response of the longer Xnr5 (773) promoter (Fig. 3A) . Examination of the sequence of the 374 bp promoter shows the deletion of both a putative Fast1 binding site and a putative Tcf/Lef binding site from the longer 773 bp fragment. Previous studies using cell dissociation, and reagents such as processed Vg1 (bVg1) and a truncated activin receptor (tAR) have shown that TGF-b signalling, at early stages, has no effect on Xnr5 expression (Takahashi et al., 2000; Rex et al., 2002) . We have therefore made no further investigation into the function of the putative Fast1 site. XTcf-3 has a previously reported repressive role in zygotic gene induction (Brannon et al., 1997; Houston et al., 2002; Yang et al., 2002b) . The loss of a Tcf/Lef site could therefore account for the observed increase in promoter activity. We note that expression of luciferase from the 243 bp fragment is lower than that of the 374 bp fragment, despite the loss of a further putative Tcf/Lef site. However, the 243 bp promoter also lacks a T-box site present in the longer promoter, which may account for decreased reporter expression.
We next asked whether the 200 bp promoter fragment resembled the endogenous Xnr5 gene in requiring b-catenin and XTcf-3 for active transcription. We therefore injected embryos with VegT mRNA together with an mRNA encoding a dominant-negative XTcf-3, which retains DNA binding activity but lacks the b-catenin binding domain (Molenaar et al., 1996) (Fig. 3B) . Expression of luciferase was substantially reduced by the presence of dominantnegative XTcf-3. The requirement for b-catenin function was confirmed by injection of VegT mRNA together with a b-catenin antisense morpholino oligonucleotide, which also led to a substantial reduction in luciferase expression.
Thus, induction of reporter expression by VegT was abolished by coinjection of either dnXTcf-3 or b-catenin morpholino. This is consistent with results obtained in a previous study, where we demonstrated that expression of the endogenous Xnr5 gene in whole embryos is dependent on the presence of b-catenin and functional XTcf-3 (Rex et al., 2002) . Therefore, within the deletion series presented here, we define Xnr5 (200) as the minimal promoter for the Xnr5 gene. The 200 bp minimal Xnr5 promoter contains two putative T-box half sites, labelled in Fig. 2B as T-box 1 and T-box 2. We generated mutations in each of these T-box sites, individually and in combination, and fused each mutated promoter to the luciferase reporter gene. Each mutated construct was tested by injection into whole embryos, with or without VegT mRNA. Mutations in either or both T-box half sites substantially reduced reporter expression in response to VegT (Fig. 4A) . The observation The proximal 785 bp of Xnr5 promoter contains putative binding sites for Tcf/Lef (underlined and lettered), T-box (underlined and numbered), Fast1 and homeodomain transcription factors. Putative sites were identified by inspection, and close matches accepted. Inspection was based upon the following consensus sequences: Tcf/Lef (a/t)(a/t)caa(a/t)gg (Travis et al., 1991; Van De Wetering et al., 1991; Van Beest et al., 2000) ; T-box full site t(g/c)acacctaggtgtgaaatt (Kispert and Herrman, 1993) ; homeodomain atta (REF); Fast1 aat(a/c)(c/t)aca (Zhou et al., 1998) . A putative TATA box was also identified by inspection (boxed). (B) A series of truncated Xnr5 promoter fragments was created from the original Xnr5 subclone. Each fragment represents a successive 5 0 deletion. The schematic diagram (not to scale) shows the position of each putative binding site identified.
that both half sites are essential for effective VegT induction is consistent with the lack of response to VegT mRNA of the Xnr5 (122) promoter (see Fig. 3A ), where T-box 2 half site is absent. The two T-box half sites are only 15 bp apart on the Xnr5 promoter and may constitute a single VegT response element. In separate experiments using promoter fragments longer than the minimal promoter defined above, mutation of an upstream T-box half site (T-box 3) had no discernible effect on response to VegT of the 374 and 243 bp promoter fragments (Fig. 4B ). The contribution of the distal T-box 4 towards VegT responsiveness of Xnr5 has not been assessed separately.
Tcf/Lef sites in the Xnr5 minimal promoter mediate repression of gene induction
Having shown in a luciferase assay that the 200 bp minimal promoter is sensitive to dnXTcf-3 and a b-catenin morpholino, we next asked whether these effects are mediated by the two putative Tcf/Lef transcription factor response elements identified in the 200 bp sequence. Mutations were created both individually and in combination. Promoter constructs were tested for response to VegT, dnXTcf-3 and the b-catenin morpholino by injection into the animal pole of one-cell embryos.
Mutations within the Tcf/Lef sites generated a range of responses (Fig. 5A ). Each mutant promoter demonstrated VegT induction that was greater than the non-mutant promoter. This was particularly evident in the case of the single A site mutation. This is consistent with a repressive function of XTcf-3. The response of the double mutant promoter to VegT was slightly higher than the response of the non-mutant promoter to VegT. This is notable because it indicates that b-catenin (acting in conjunction with Tcf/Lef factors) does not have a major positive role as a transcriptional co-activator, but rather suggests that the main role of b-catenin in Xnr5 gene expression is to lift the repression imposed by the binding of XTcf-3 or related molecules. Positive activation by VegT can only occur where this repression is lifted.
The effect of dnXTcf-3 mRNA on the VegT induction of each single Tcf/Lef mutant promoter was to decrease reporter gene induction, although the amount of expression is still higher than with the non-mutant promoter. Importantly, dnXTcf-3 had no significant effect upon VegT induction of the double mutant. In other words, the elimination of XTcf-3 response elements from the promoter allowed promoter activation by VegT in the presence of dnXTcf-3.
To test the response of the double Tcf/Lef site mutant to endogenous signals in the embryo, we injected the wild-type and Tcf/Lef site mutant constructs into two blastomeres of a four-cell embryo, injections being targeted either dorsally or ventrally. At stage 10.25, dorsally-and ventrally-injected embryos were separately assayed for levels of luciferase activity (Fig. 5B) . Xnr5 is normally expressed in the future dorsal endoderm region of the embryo (Takahashi et al., 2000) . In agreement with this, the wild-type 200 bp promoter activated expression of luciferase to high levels in the dorsal half of the embryo, with low amounts expressed in the ventral half. By contrast, there was no significant difference between dorsal and ventral reporter gene expression upon targeted injection of the Tcf/Lef double mutant promoter. Thus, the Tcf/Lef sites in Xnr5 (200) are required for restricting expression to the dorsal side of the embryo. This provides further evidence that the role of XTcf-3, or related molecules, in the induction of Xnr5 is a repressive one.
2.5. Overexpression of either XTcf-3 or XLef-1 can rescue Xnr5 expression in a dnXTcf-3-injected embryo Three members of the Tcf/Lef family have so far been identified in Xenopus, XTcf-3 (Molenaar et al., 1996) , XTcf-4 (König et al., 2000) and XLef-1 . XTcf-3 is maternally expressed throughout the embryo, whereas XLef-1 expression can be first detected on the dorsal side at MBT. In the original study, XTcf-4 was first detected at neurula stages (König et al., 2000) , too late to influence expression in the blastula embryo. We have not investigated a potential role for this factor in the induction of Xnr5. However, there is very recent evidence to show that XTcf-4 is present in the unfertilised egg (Houston et al., 2002) .
We asked whether both XTcf-3 and XLef-1 are capable of overcoming the effect of dnXTcf-3 upon endogenous Xnr5 expression in whole embryos (Fig. 6A ). Embryos were injected into the vegetal pole at the one-cell stage with dnXTcf-3 mRNA, which led to loss of Xnr5 expression. Subsequently at the four-cell stage, embryos were injected at the equatorial region with either full-length XTcf-3 or XLef-1 mRNA and the effect on Xnr5 expression assessed by RT-PCR. Full-length XTcf-3 mRNA rescued the expression of Xnr5 to normal levels at all amounts injected. XLef-1 mRNA rescued, but less efficiently. This suggests that XLef-1 is capable of competing with dnXTcf-3 for promoter sites. Phenotypically, injection of dnXTcf-3 'ventralised' the embryos and we observed no axis rescue with any injection of XTcf-3 or XLef-1 (data not shown).
Unlike other members of the Tcf/Lef family, Lef factors have been identified as having an intrinsic, contextdependent transactivation domain (Gradl et al., 2002; Carlsson et al., 1993) . Although the distinct roles of members of this family with their multiple splicing isoforms have yet to be fully characterised, we asked whether XLef-1 is able to participate in transactivating the endogenous Xnr5 gene on the ventral side of the embryo. XLef-1 mRNA was injected into the ventral side of four-cell stage embryos and endogenous Xnr5 gene expression assessed in dorsal and ventral halves of bisected embryos by RT-PCR (Fig. 6B) . Expression of XLef-1 on the ventral side of the embryo led to ectopic ventral expression of Xnr5, suggesting that XLef-1 is capable of activating Xnr5 expression in the absence of b-catenin, presumably via the intrinsic activation domain.
A number of other transcription factors, including members of the Sox family, have a DNA-binding domain (HMG box) similar to XTcf-3 (Zorn et al., 1999) . It is therefore possible that overexpression of dnXTcf-3 could interfere with these b-catenin-independent pathways. We therefore tested the ability of b-catenin to induce expression of Xnr5 on the ventral side (Fig. 6B) . Ectopic expression of b-catenin on the ventral side led to ectopic expression of Xnr5 on the ventral side. The amount of ventral Xnr5 expression matched the normal amount observed dorsally, indicating that b-catenin is normally limiting on the ventral side. These results indicate that repression of Xnr5 can be overcome by b-catenin, consistent with repression of the endogenous gene being mediated by Tcf/Lef factors.
The 200 bp minimal promoter directs expression of a transgene to the dorsal endomesoderm
The activity of the minimal promoter as defined above was tested by transgenesis. Both the 773 and the 200 bp wild-type promoter fragments were ligated to a nuclear b-galactosidase reporter gene as described previously (Hyde and Old, 2000) . Transgenic embryos were generated by the standard restriction enzyme-mediated integration technique (Kroll and Amaya, 1996) . Embryos were harvested at stage 9 through 10.5 and stained for bgalactosidase activity. Both the 773 and the 200 bp promoter fragments directed expression of b-galactosidase in a well-defined dorsal domain (Fig. 7A -E) . Externally, this activity was apparent as a patch of nuclear stain coincident with the future blastopore at stage 9 and marking the dorsal blastopore lip at stage 10.5. Bisection of the embryos to show the internal staining pattern revealed activity extending deep into the endomesoderm. We can conclude that both the 773 and the 200 bp wild-type promoter fragments are functional in driving transgene expression and are capable of mimicking the normal pattern of Xnr5 expression at the stages examined.
2.7. Mutations in the Tcf/Lef sites of the 200 bp minimal promoter abolish dorsal specificity and direct expression more broadly in the vegetal region Experiments described above led us to conclude that dorsal-specific expression of Xnr5 is dependent upon lifting the repression conferred by XTcf-3 or related factors which bind to the A and B sites of the 200 bp minimal promoter. We therefore asked whether mutation of both the A and the B sites in this minimal promoter would alter the dorsal-specific transgene expression directed by the wild-type promoter. Mutation of these Tcf/Lef sites resulted a lower frequency of active transgene expression and the complete abolition of dorsal specificity (Fig. 7F -I ). The double mutant promoter directed patchy expression throughout the vegetal region at stages 9 and 10.5. This was evident both externally and in deeper cells within bisected embryos. Although the mechanism underlying the non-uniform expression in the vegetal region is not clear, we conclude that the dorsal specificity of transgene expression is dependent on the presence of functional Tcf/Lef sites within the promoter.
Discussion
The Xnr5 sequence
The Xnr5 genomic sequence clone isolated contained at least 785 bp of upstream sequence and all coding and intronic sequences. We identified multiple putative response elements in the upstream promoter region, including several for Tcf/Lef and T-box transcription factors. This was expected from previous work where the endogenous Xnr5 gene was shown be induced by VegT in animal caps, this induction being dependent on functional Wnt/b-catenin signalling. The functions of the Fast1 and homeodomain sites identified were not investigated in this study. Previous work has shown that TGF-b signalling has no effect on Xnr5 expression during early stages (Takahashi et al., 2000; Rex et al., 2002) . The generation of a minimal promoter consisting of only 200 bp of wild-type sequence was sufficient to direct expression in luciferase assays and transgenic experiments in a pattern recapitulating endogenous Xnr5 expression at stage 9-10.5. The 200 bp sequence contains the putative TATA box and 100 bp of sequence 3 0 to this. The functional sites required to direct Xnr5 expression therefore appear to be contained within a relatively short length of sequence. However, the contribution of more remote elements cannot be ignored. There may be functional redundancy between the T-box sites and between the Tcf/Lef sites further upstream than the minimal promoter. The mutation of T-box 3 had little effect on the VegT activation of the 374 and 243 bp promoter < luciferase constructs. However, the function of the downstream T-box 1 and T-box 2 were only examined in the context of the 200 bp promoter, where both were found to be necessary. Mutation of these T-box(es) in longer promoters may yield different results.
The model
Our previous work on the regulation of Xenopus nodalrelated genes (Rex et al., 2002) demonstrated the role of b-catenin in the induction of Xnr5 and Xnr6. We showed that while b-catenin alone (stimulated by XWnt-8 injection) was unable to induce either gene, functional b-catenin was required for endogenous induction of Xnr5 and Xnr6. Recent work by Houston and colleagues has shown that the removal of XTcf-3 from oocytes (by antisense oligonucleotide depletion methods) allows inappropriate induction of dorsal-specific genes on the ventral side of the embryo (Houston et al., 2002) . A model was proposed in which XTcf-3 has a repressive function on the ventral side of the normal embryo so as to prevent such inappropriate activation. The role of XTcf-3 as a repressor fits our data and our model for the regulation of Xnr5 is shown in Fig. 8 . We propose that, throughout the embryo, XTcf-3 represses the Xnr5 promoter, presumably through binding factors such as Groucho and XCtBP (Brannon et al., 1999) . In the absence of b-catenin, this repression overrides activation. On the dorsal side, the binding of b-catenin to XTcf-3 lifts this repression and allows induction by a positively-acting transcription factor, in this case VegT.
The mechanism by which b-catenin might lift repression conferred by XTcf-3 is unknown. There are several ways which we predict b-catenin might fulfil this role. The simplest model is that b-catenin disrupts the XTcf3/Groucho/XCtBP ternary complex and displaces these repressive factors. An alternative explanation lies in the structure of the Tcf/DNA complex. The Tcf/Lef family of transcription factors are HMG-box proteins. These proteins have the ability to physically bend the DNA to which they are bound (Giese et al., 1992) ; indeed, it has been proposed that this ability to alter the physical structure of DNA and subsequently recruit other transcription factors is the main function of HMG-box proteins (Love et al., 1995) . Previous studies have shown that mLef-1 alone can bend DNA around 1208; binding in a ternary complex with b-catenin can decrease this bending effect (Behrens et al., 1996) . If the bending of DNA by Tcf/Lef binding exerts some repressive influence, this may be overcome by b-catenin also binding. A third explanation for the mechanism by which b-catenin lifts repression is that b-catenin may promote the transition from methylated DNA to an unmethylated form which can be activated by VegT. Previous work with the regulatory regions of Xbra has shown that the activation of transcription at MBT may in part be due to demethylation at particular CG dinucleotides (Stancheva and Meehan, 2000) . However, with standard methods using methylation-sensitive isoschizomeric enzymes (HpaII and MspI), we have been unable to detect a change in methylation at the Xnr5 locus upon injection of XWnt8 (or activin or VegT) in animal caps (data not shown). Thus the role of b-catenin does not appear to involve changes in DNA methylation.
Previous work on the regulation of the siamois gene highlighted a role for XTcf-3 as a repressive element (Brannon et al., 1997) . In that study, mutation of the Tcf/Lef binding sites in the siamois promoter allowed activation of a reporter gene on the ventral side of the embryo. On the dorsal side of the embryo, this repression is overcome by the binding of b-catenin. For the case of siamois, it appears that b-catenin fulfils a dual role by both lifting repression and activating transcription. Evidence that b-catenin is positively regulating transcription of siamois was shown by decreased activation of the promoter to well below wildtype levels upon mutation of Tcf/Lef sites. By contrast, in a parallel experiment shown in this study (Fig. 5) , mutation of individual Tcf/Lef sites in the Xnr5 promoter led to enhanced expression of the promoter < luciferase contrast. The regulation of Xnr5 is therefore somewhat different from that of siamois, because for Xnr5 the role of b-catenin is largely to lift repression and positive transactivation is dependent upon a second, localised, maternal transcription factor, i.e. VegT.
A minor transactivating role for b-catenin?
The model we have proposed above does not include a major transactivating role for b-catenin. The data shown in Fig. 5B suggest that, while the main role of b-catenin may be to lift repression by XTcf-3, there may also be a minor positive requirement for b-catenin. If the only role for bcatenin is to solely lift repression, we would expect activation of the double Tcf/Lef mutant promoter by VegT to be higher than activation observed with each single Tcf/Lef mutant. This is not the case. However, activation of the double mutant promoter by VegT is comparable with activation of the wild-type promoter by VegT. A positive requirement for b-catenin may not be necessary as wild-type levels of induction can be achieved without either Tcf/Lef site in the 200 bp promoter. We cannot, however, exclude a minor positive requirement for b-catenin operating in a Tcf/Lef-independent manner via an unidentified site in the promoter.
The role of XLef-1
From the results presented above, we cannot discriminate possible different roles of members of the Tcf/Lef family in the induction of Xnr5. Since all members of the family bind to the same consensus sequence, as will other HMG-box containing proteins, we assume that injected dnXTcf-3, present in a large excess in the embryo, will successfully compete for all Tcf/Lef promoter sites. There is evidence that this assumption is correct because both XTcf-3 and XLef-1 can rescue the effect on Xnr5 transcription by dnXTcf-3, i.e. different family members can successfully compete for the same binding site (Fig. 6 ). XLef-1 was also shown to activate Xnr5 transcription on the ventral side of the embryo. This suggests a role for XLef-1 in regulating Xnr5 in the blastula. XLef-1 expression is first detected after MBT in anterior and dorsal regions of the embryo . At this stage, XLef-1 might compete with XTcf-3 for binding to the Xnr5 promoter, consistent with the results of Fig. 6 . Therefore as amounts of XLef-1 accumulate in the post-MBT embryo, XLef-1 may contribute to the maintenance of Xnr5 expression by displacing XTcf-3 from the promoter. With the accumulation of XLef-1, the requirement for b-catenin may therefore be superseded.
The ultra-early and dynamic expression of Xnr5
The data and model presented above are intended to elucidate the first substantial expression of Xnr5, i.e. dorsalvegetal expression at the early blastula stage. We have addressed the main domain of expression of Xnr5, that in the dorsal-vegetal region of the embryo. However, there are further refinements required to explain fully the dynamic expression of this nodal-related gene. Takahashi et al. (2000) reported transient expression of Xnr5 throughout the vegetal region of the embryo at stage 9 (expression at stage 8.5, expression is dorsal-vegetal). The model proposed in Fig. 8 shows expression of Xnr5 dependent on the presence of b-catenin. The transient expression throughout the vegetal pole of stage 9 embryos is therefore not well explained by our model because results in Fig. 6 show that, at stage 10.25, b-catenin is limiting on the ventral side of the embryo, and we would assume this to be the case at earlier stages. In the same figure, we also showed that expression of XLef-1 on the ventral side of the embryo allowed expression of Xnr5. In a recent study, Roël et al. (2002) , showed that XLef-1 has a role in mediating canonical Wnt signalling in ventrolateral regions of the embryo, implying the presence of this transcription factor on the ventral side. It may be the case that initial expression of XLef-1 at the MBT may lead to transient expression of Xnr5 on the ventral side of the embryo.
The nodal-related genes represent a gene family where the detailed expression dynamics of each member is different. For example, Xnr5 and Xnr6 are expressed ultraearly, prior to MBT, at an earlier stage that the remaining family members (Yang et al., 2002a) . We have demonstrated that Xnr5 expression is dependent on b-catenin and VegT. The ultra-early expression of Xnr5 or Xnr6 is only possible because of the sufficiency of these maternal factors for expression of the two genes, according to our model. However, one or both of these maternal factors are also important for expression of other nodal-related genes (Hyde and Old, 2000; McKendry et al., 1997; Takahashi et al., 2000; Rex et al., 2002) and their sufficiency or otherwise requires further investigation. Further examination of the promoter function coupled with further understanding of chromatin remodelling around the midblastula transition may provide answers to this problem.
Experimental procedures
Embryos and injections
Embryos were obtained and cultured by standard methods and staged according to Nieuwkoop and Faber (1967) . Injections were performed at one-or four-cell stage (indicated in Section 2) using a Drummond microinjector to inject 13.8 nl. During and after injections, embryos were maintained in 6% Ficoll in 0.1 £ Barth's saline and incubated at 13 or 18 8C.
Morpholino oligonucleotide
The antisense morpholino oligonucleotide, directed against b-catenin mRNA, was identical to that used previously in initial studies of morpholino use in Xenopus (Heasman et al., 2000) , having the sequence 5 0 tttcaaccgtttccaaagaaccagg 3 0 . The oligonucleotide was obtained from Gene Tools Inc. The specificity of this morpholino has been further confirmed by our previously published comparisons between the effects of this morpholino and dnXTcf-3 expression, upon all six Xnr gene family members. The diverse and distinct responses of each of the Xnr genes were closely similar for both reagents (Rex et al., 2002) .
Library screening and cloning
An adult Xenopus laevis genomic library in lGEM-11 (Promega) (library a gift of M.L. King) was screened at high stringency with a radiolabelled PCR product amplified using previously described primers to amplify bases 29 to 430 of Xnr5 cDNA (Takahashi et al., 2000) . A positive clone was identified and recombinant phage DNA isolated and digested in individual reactions with BamHI, SstI and XhoI. All fragments were subcloned into pBlueScriptII KS (Invitrogen) and sequenced to identify those containing significant upstream sequence. The subclone used to originate this study was named Xnr5 SstI pBS.
Preparation of synthetic mRNA for injection
Plasmids were linearised and capped mRNA synthesised from the appropriate promoter using a mMessage mMachine kit (Ambion). Plasmids were generous gifts of M. Molenaar (XTcf-3, dnXTcf-3, XLef-1), R. Moon (bcatenin) and D. Clements (VegT, XWnt8 (originally Smith and Harland, 1991) ).
RT-PCR analysis
Total RNA was prepared from embryos as previously described (Hyde and Old, 2000) . 0.5 -1 mg of RNA was reverse transcribed using MMLV (Invitrogen). PCRs were carried out using the following primers: EF1a-Forward 5 
PCR mutagenesis by hybrid overlap extension
Mutations in the cloned Xnr5 promoter were generated in both T-box and Tcf/Lef sites by PCR-based hybrid overlap extension. Mutations were created as follows: T-box 1-tgtcacct to tgtaatgt; T-box 2-agtgtgaa to aatatgca; T-box 3-tgtcacct to agtcgact; Tcf/Lef A-atgaaag to atgcacg; Tcf/Lef B-gtttgat to gctcgat.
Luciferase reporter gene assays
Promoter fragments were inserted into a vector containing a luciferase reporter gene, pGL3-Basic (Promega). To assay for promoter activity, embryos were injected with 50 pg of circular test plasmid and various amounts of synthetic mRNA (as indicated in Section 2). Embryos were harvested at stage 10.25 and cell extract prepared as previously described (Hyde and Old, 2000) . In each experiment, approximately 10 embryos were used to make cell extract and 3 embryo equivalents used in each assay. Each assay was completed in duplicate or triplicate and repeated several times independently.
Transgenesis
Promoter fragments were ligated into a vector containing a nuclear b-galactosidase reporter gene (Hyde and Old, 2000) . Plasmid constructs were linearised with NotI and purified using a QIAquick Gel Extraction Kit (Qiagen). Transgenic embryos were generated by restriction enzyme mediated integration following the technique of Kroll and Amaya, 1996 . Embryos were fixed briefly at various stages at room temperature for 1 h using 4% formaldehyde. Nuclear b-galactosidase activity was visualised in a standard colour reaction by incubation at 37 8C for 24-36 h.
